Welcome to our dedicated page for Regional Health Pptys SEC filings (Ticker: RHEPZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Regional Health Pptys's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Regional Health Pptys's regulatory disclosures and financial reporting.
Regional Health Properties, Inc. entered into forbearance agreements with Cadence Bank covering loan defaults tied to a $5,000,000 USDA Note and a $800,000 SBA Note, both originally due on July 27, 2036. The agreements, effective February 1, 2026, require a one-time forbearance payment of $21,047.76 and a $6,764.21 2026 USDA annual renewal fee by February 27, 2026. During the forbearance period through February 1, 2027, the company and borrower must continue monthly principal and interest payments under existing note terms. At the end of this period, remaining balances on both notes, including principal, interest, late charges and statutory attorney’s fees, become due.
Regional Health Properties, Inc. amendment to a Schedule 13G/A reports updated beneficial ownership as of December 31, 2025. The Radoff Family Foundation directly owned 109,888 Shares (including 25,681 shares underlying Series D Preferred), representing 2.8% of the class. Bradley L. Radoff directly owned 227,821 Shares (including 61,051 shares underlying Series D Preferred), and may be deemed to beneficially own an aggregate of 337,709 Shares, or 8.4%, based on 3,934,677 Shares outstanding as of November 14, 2025. The filing states the Reporting Persons disclaim beneficial ownership of securities not directly owned.
Regional Health Properties, Inc. reports a beneficial ownership disclosure by the Radoff Family Foundation and Bradley L. Radoff. As of the close of business on August 15, 2025, Radoff Foundation directly owned 102,725 Shares and Mr. Radoff beneficially owned an aggregate of 277,507 Shares.
The filing states these totals include shares underlying the Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares: 25,681 Shares counted for Radoff Foundation and 22,939 Shares counted for Mr. Radoff. The percentages reported are 2.7% for Radoff Foundation and 7.1% for Mr. Radoff, based on 3,837,639 Shares outstanding as of August 15, 2025.
Regional Health Properties director Steven L. Martin was granted 3,000 stock options. On January 16, 2026, he received non-qualified stock options to buy 3,000 shares of common stock at an exercise price of $1.30 per share. The options were granted under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan, vest immediately, and are exercisable until January 16, 2036.
Regional Health Properties director receives stock option grant
Regional Health Properties, Inc. reported that director Steven J. Baileys received a grant of 3,000 non-qualified stock options on January 16, 2026. These options allow him to buy common stock at an exercise price of $1.30 per share, based on the average high/low OTC price that day.
The options vest immediately under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan. Following this grant, Baileys directly holds 3,000 derivative securities linked to Regional Health Properties common stock.
Regional Health Properties director receives stock options grant. Director Kenneth Wayne Taylor was granted non-qualified stock options for 3,000 shares of Regional Health Properties, Inc. common stock on January 16, 2026. The options were issued under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan, vest immediately, and have a $1.30 exercise price based on the average of the high and low OTC trading prices on the grant date.
Regional Health Properties, Inc. director Gene E. Burleson was granted 3,000 non-qualified stock options on January 16, 2026. The options have an exercise price of $1.30 per share, based on the average of that day’s high and low OTC prices, and vest immediately.
The options, granted under Regional Health Properties’ Amended and Restated 2023 Omnibus Incentive Compensation Plan, are exercisable into 3,000 shares of common stock until January 16, 2036. Following this grant, Burleson directly holds 3,000 derivative securities in the form of these stock options.
Regional Health Properties, Inc. director F. Scott Kellman reported receiving a grant of 3,000 non-qualified stock options on January 16, 2026 under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan. The options have an exercise price of $1.30, based on the average of that day’s OTC high and low, vest immediately, and leave him with 3,000 derivative securities beneficially owned directly.
Regional Health Properties director granted stock options. Director C. Christian Winkle received 3,000 non-qualified stock options to buy Regional Health Properties common stock. The options have an exercise price of $1.30 per share, based on the average of that day's OTC trading range, and vest immediately. They are exercisable starting January 16, 2026 and expire on January 16, 2036. Following this grant, Winkle directly holds 3,000 derivative securities, which were issued under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan.
Regional Health Properties, Inc. reported the results of its 2025 Annual Meeting of Shareholders held on January 5, 2026 in Atlanta. Common stockholders elected four directors to serve until the 2026 annual meeting, while holders of the Series B and Series D preferred stock each elected their designated directors.
Common stockholders approved the Amended and Restated 2023 Omnibus Incentive Compensation Plan and, by advisory vote, approved the compensation of the named executive officers. They expressed a preference to hold future Say‑on‑Pay votes every three years and ratified Cherry Bekaert, LLP as independent registered public accounting firm for the year ending December 31, 2025.